David D. Guilmette

David D. Guilmette has built a distinguished career in the healthcare and benefits industry through senior leadership roles at major organizations, including serving as CEO of Global Health Solutions at Aon plc, President roles at Cigna Group, and Managing Director at Towers Perrin. " " "

Throughout his career, he has driven strategic transformation initiatives and performance enhancements, notably in his roles that involved innovation, commercial partnerships, and large-scale solution development. His leadership has been instrumental in executing significant operational shifts and promoting technology-rich services. " "

At ALIT, his appointment as CEO on 08-20-2024, following his earlier involvement as a board member and Vice Chair, marks a transformative phase for the company. In addition to his executive responsibilities, he has engaged with non-profit initiatives and contributed to the broader industry through board positions with companies such as SwordHealth and entrepreneurial ventures like WorldClass Health. " " " "

Performance-Vested RSUs

Grant Details:

• Grant Date: October 1, 2024 "
• Target Number of RSUs: 450,762 "
• Weights: 50% for Revenue Tranche and 50% for Adjusted EBITDA Tranche "

Evaluation Period & Vesting Schedule:

• Measurement Period: January 1, 2024 to December 31, 2026 "
• Certification Date: Within 60 days after the Measurement Period (by March 1, 2027) "

Additional Details:

• Vesting is contingent upon achieving the specified performance thresholds in both metrics. The vesting percentage can range from 50% to 200% of the target RSUs based on performance. "
• Grant Date Fair Value and Grant Date Stock Price are not provided.